World
US approves first oral pill for treatment of COVID
The US Food and Drug Administration (FDA) has authorised Pfizer’s antiviral pill, Paxlovid, to treat COVID-19.
This is the first antiviral COVID-19 pill authorised for sick people to take at home before they are sick enough to be hospitalised.
Paxlovid combines a new antiviral drug named nirmatrelvir and an older one called ritonavir and is administered as three pills given twice a day for five days.
In a statement on Wednesday, the FDA said those eligible for the pill include high-risk individuals age 12 and older who weigh at least 88 pounds and have a positive SARS-CoV-2 test are eligible.
It said Paxlovid is available by prescription only and should be initiated as soon as possible after diagnosis of COVID-19 and within five days of symptom onset.
Patrizia Cavazzoni, director of the FDA’s Center for Drug Evaluation and Research, said the pill is a major step forward in the fight against this global pandemic.
Bodex F. Hungbo, SPMIIM is a multiple award-winning Nigerian Digital Media Practitioner, Digital Strategist, PR consultant, Brand and Event Expert, Tv Presenter, Tier-A Blogger/Influencer, and a top cobbler in Nigeria.
She has widespread experiences across different professions and skills, which includes experiences in; Marketing, Media, Broadcasting, Brand and Event Management, Administration and Management with prior stints at MTN, NAPIMS-NNPC, GLOBAL FLEET OIL AND GAS, LTV, Silverbird and a host of others
